(CABK) Caixabank - Overview
Exchange: MC •
Country: Spain •
Currency: EUR •
Type: Common Stock •
ISIN: ES0140609019
Stock:
Total Rating 50
Risk 53
Buy Signal -0.39
| Risk 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Relative Tail Risk | 3.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.79 |
| Alpha | 58.32 |
| Character TTM | |
|---|---|
| Beta | 0.549 |
| Beta Downside | 1.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.40% |
| CAGR/Max DD | 2.70 |
EPS (Earnings per Share)
Revenue
Description: CABK Caixabank
CaixaBank, S.A., together with its subsidiaries, provides various banking products and services for individuals and businesses in Spain, Portugal, and internationally. It operates through Banking and Insurance, BPI, and Corporate Centre segments. The company offers retail, private, business, institutional, corporate and investment, premier, InTouch, and international banking; payment methods; savings and investment products; financing; life, life-risk, and non-life insurance; traditional financial and independent advice, and broker services; ATMs; pension fund management; asset and wealth management; securitisation fund management; consumer finance; IT services; and back-office administration services. It also engages in the management of collective investment institutions; holding of property assets; venture capital company; promotion of business and entrepreneurial initiatives; development of digital projects; vehicle and equipment leasing; project management, maintenance, logistics, and procurement; marketing of products and cashless platforms; mortgage loan management; digital business; hotels; private security of goods and people; shopping center real estate; administration, management, development, and operation of real estate; and reinsurance activities. The company was formerly known as Criteria CaixaCorp, S.A. and changed its name to CaixaBank, S.A. in July 2011. CaixaBank, S.A. was founded in 1904 and is based in Valencia, Spain.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 5.89b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.0 > 0.02 and ΔFCF/TA -2.62 > 1.0 |
| NWC/Revenue: -2056 % < 20% (prev -2275 %; Δ 218.5% < -1%) |
| CFO/TA 0.00 > 3% & CFO 2.94b > Net Income 5.89b |
| Net Debt (6.38b) to EBITDA (6.57b): 0.97 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.03b) vs 12m ago -1.18% < -2% |
| Gross Margin: 91.02% > 18% (prev 0.67%; Δ 9034 % > 0.5%) |
| Asset Turnover: 3.04% > 50% (prev 2.60%; Δ 0.44% > 0%) |
| Interest Coverage Ratio: 0.61 > 6 (EBITDA TTM 6.57b / Interest Expense TTM 7.35b) |
Altman Z''
| A: -0.61 (Total Current Assets 45.83b - Total Current Liabilities 450.94b) / Total Assets 664.04b |
| B: error (Retained Earnings missing) |
| C: 0.01 (EBIT TTM 4.48b / Avg Total Assets 647.52b) |
| D: -0.00 (Book Value of Equity -452.0m / Total Liabilities 625.51b) |
Beneish M
| DSRI: none (Receivables none/216.0m, Revenue 19.70b/16.41b) |
| GMI: 0.74 (GM 91.02% / 67.40%) |
| AQI: 1.01 (AQ_t 0.92 / AQ_t-1 0.91) |
| SGI: 1.20 (Revenue 19.70b / 16.41b) |
| TATA: 0.00 (NI 5.89b - CFO 2.94b) / TA 664.04b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of CABK shares?
As of February 25, 2026, the stock is trading at EUR 10.66 with a total of 8,596,645 shares traded.
Over the past week, the price has changed by +3.75%, over one month by -0.37%, over three months by +15.19% and over the past year by +73.93%.
Over the past week, the price has changed by +3.75%, over one month by -0.37%, over three months by +15.19% and over the past year by +73.93%.
Is CABK a buy, sell or hold?
Caixabank has no consensus analysts rating.
What are the forecasts/targets for the CABK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.2 | 5% |
| Analysts Target Price | - | - |
CABK Fundamental Data Overview February 22, 2026
Market Cap USD = 90.44b (76.74b EUR * 1.1784 EUR.USD)
P/E Trailing = 13.8797
P/E Forward = 11.8906
P/S = 5.0134
P/B = 1.8375
Revenue TTM = 19.70b EUR
EBIT TTM = 4.48b EUR
EBITDA TTM = 6.57b EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 52.21b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.38b EUR (from netDebt column, last quarter)
Enterprise Value = 83.12b EUR (76.74b + Debt 52.21b - CCE 45.83b)
Interest Coverage Ratio = 0.61 (Ebit TTM 4.48b / Interest Expense TTM 7.35b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 83.12b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 19.70b)
Net Margin = 29.90% (Net Income TTM 5.89b / Revenue TTM 19.70b)
Gross Margin = 91.02% ((Revenue TTM 19.70b - Cost of Revenue TTM 1.77b) / Revenue TTM)
Gross Margin QoQ = 69.89% (prev none%)
Tobins Q-Ratio = 0.13 (Enterprise Value 83.12b / Total Assets 664.04b)
Interest Expense / Debt = 14.08% (Interest Expense 7.35b / Debt 52.21b)
Taxrate = 32.07% (696.0m / 2.17b)
NOPAT = 3.04b (EBIT 4.48b * (1 - 32.07%))
Current Ratio = 0.10 (Total Current Assets 45.83b / Total Current Liabilities 450.94b)
Debt / Equity = 1.36 (Debt 52.21b / totalStockholderEquity, last quarter 38.51b)
Debt / EBITDA = 0.97 (Net Debt 6.38b / EBITDA 6.57b)
Debt / FCF = unknown (Net Debt 6.38b / FCF TTM 0.0)
Total Stockholder Equity = 38.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.91% (Net Income 5.89b / Total Assets 664.04b)
RoE = 15.47% (Net Income TTM 5.89b / Total Stockholder Equity 38.08b)
RoCE = 2.10% (EBIT 4.48b / Capital Employed (Total Assets 664.04b - Current Liab 450.94b))
RoIC = 3.39% (NOPAT 3.04b / Invested Capital 89.79b)
WACC = 8.60% (E(76.74b)/V(128.95b) * Re(7.94%) + D(52.21b)/V(128.95b) * Rd(14.08%) * (1-Tc(0.32)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.29%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 84.49 | EPS CAGR: 25.35% | SUE: 0.78 | # QB: 0
Revenue Correlation: 90.67 | Revenue CAGR: 22.39% | SUE: 1.54 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.20 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=0.88 | Chg7d=+0.012 | Chg30d=+0.030 | Revisions Net=+12 | Growth EPS=+5.9% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=0.99 | Chg7d=+0.016 | Chg30d=+0.064 | Revisions Net=+13 | Growth EPS=+12.9% | Growth Revenue=+8.3%
[Analyst] Revisions Ratio: +1.00 (12 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 7.9% - Earnings Yield 7.2%)
[Growth] Growth Spread = +1.8% (Analyst 2.6% - Implied 0.7%)
P/E Trailing = 13.8797
P/E Forward = 11.8906
P/S = 5.0134
P/B = 1.8375
Revenue TTM = 19.70b EUR
EBIT TTM = 4.48b EUR
EBITDA TTM = 6.57b EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 52.21b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.38b EUR (from netDebt column, last quarter)
Enterprise Value = 83.12b EUR (76.74b + Debt 52.21b - CCE 45.83b)
Interest Coverage Ratio = 0.61 (Ebit TTM 4.48b / Interest Expense TTM 7.35b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 83.12b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 19.70b)
Net Margin = 29.90% (Net Income TTM 5.89b / Revenue TTM 19.70b)
Gross Margin = 91.02% ((Revenue TTM 19.70b - Cost of Revenue TTM 1.77b) / Revenue TTM)
Gross Margin QoQ = 69.89% (prev none%)
Tobins Q-Ratio = 0.13 (Enterprise Value 83.12b / Total Assets 664.04b)
Interest Expense / Debt = 14.08% (Interest Expense 7.35b / Debt 52.21b)
Taxrate = 32.07% (696.0m / 2.17b)
NOPAT = 3.04b (EBIT 4.48b * (1 - 32.07%))
Current Ratio = 0.10 (Total Current Assets 45.83b / Total Current Liabilities 450.94b)
Debt / Equity = 1.36 (Debt 52.21b / totalStockholderEquity, last quarter 38.51b)
Debt / EBITDA = 0.97 (Net Debt 6.38b / EBITDA 6.57b)
Debt / FCF = unknown (Net Debt 6.38b / FCF TTM 0.0)
Total Stockholder Equity = 38.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.91% (Net Income 5.89b / Total Assets 664.04b)
RoE = 15.47% (Net Income TTM 5.89b / Total Stockholder Equity 38.08b)
RoCE = 2.10% (EBIT 4.48b / Capital Employed (Total Assets 664.04b - Current Liab 450.94b))
RoIC = 3.39% (NOPAT 3.04b / Invested Capital 89.79b)
WACC = 8.60% (E(76.74b)/V(128.95b) * Re(7.94%) + D(52.21b)/V(128.95b) * Rd(14.08%) * (1-Tc(0.32)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.29%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 84.49 | EPS CAGR: 25.35% | SUE: 0.78 | # QB: 0
Revenue Correlation: 90.67 | Revenue CAGR: 22.39% | SUE: 1.54 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.20 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=0.88 | Chg7d=+0.012 | Chg30d=+0.030 | Revisions Net=+12 | Growth EPS=+5.9% | Growth Revenue=+5.6%
EPS next Year (2027-12-31): EPS=0.99 | Chg7d=+0.016 | Chg30d=+0.064 | Revisions Net=+13 | Growth EPS=+12.9% | Growth Revenue=+8.3%
[Analyst] Revisions Ratio: +1.00 (12 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 7.9% - Earnings Yield 7.2%)
[Growth] Growth Spread = +1.8% (Analyst 2.6% - Implied 0.7%)